Drug-Eluting Balloon Technology for Native Non-Small Coronary Artery Disease: Another Crusade against Skepticism!

Publisher： Karger

E-ISSN： 1421-9751|137|1|22-24

ISSN： 0008-6312

Source： Cardiology, Vol.137, Iss.1, 2016-12, pp. : 22-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of Small Vessel Disease With the Paclitaxel Drug‐Eluting Balloon: 6‐Month Angiographic and 1‐Year Clinical Outcomes of the Spanish Multicenter Registry

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 5, 2015-10 ,pp. : 430-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of percutaneous coronary intervention with drug‐eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five‐years after intervention

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1029-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison between Drug-Eluting Stents and Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: A Meta-Analysis of Two Randomized Trials and Thirteen Observational Studies

By  

Cardiology, Vol. 118, Iss. 1, 2011-03 ,pp. : 22-32

Karger

Access to resources Recommend Favorite

CABG versus DES in diabetic patients

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 2, 2015-03 ,pp. : 192-201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary percutaneous coronary intervention by drug‐eluting balloon angioplasty: The nonrandomized fourth arm of the DEB‐AMI (drug‐eluting balloon in ST‐segment elevation myocardial infarction) trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. S1, 2015-10 ,pp. : S34-S44

John Wiley & Sons Inc

Access to resources Recommend Favorite